Technology Review - Published By MIT
Advertisement
TO READ THIS STORY - you must have a paid subscription to Technology Review OR you can purchase special archive reading credits here. Choose from these great offers below.
I'm a paid subscriber please
log me in
I want to purchase this article for
only 99¢
(requires login)
I want to purchase five articles for
only $3.99
(requires login)
I want to buy
1 Year TOTAL Access for
only $24.95
(requires login)

Please note: Click here if you are currently a Technology Review print or digital subscriber and do not have access to this article.

February 2004

Digestive Diagnostics

The latest biotech "-omics," metabolomics, could lead to earlier detection of a wide array of diseases.

By Corie Lok

Meet another installment in biotech's "-omics" series: metabolomics. While doctors have been charting levels of individual metabolites like cholesterol for years, a growing number of researchers are measuring hundreds of metabolites-fatty acids, amino acids, and sugars produced by cells' everyday activities-more systematically. They say this will enable earlier diagnoses of a wide array of diseases and provide a set of new tools for developing safer drugs.

Select from the choices above
to read the entire article.


Log In

Forgot your password?     Register »
Advertisement

Videos

Laser-Triggered Chemical Reactions
Advertisement
Advertisement
Advertisement
Subscribe to Technology Review's daily e-mail update. Enter your e-mail address

TECHNOLOGY RESOURCES

More Technology News from Forbes

Advertisement
MIT Massachusetts Institute of Technology © 2009 Technology Review. All Rights Reserved.